Cumberland Share Price

Cumberland Share Price

NASDAQ: CPIX | Micro Cap | Healthcare
$6.63
+$1.03 (18.39%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cumberland Stock Performance

Open
$5.55
Prev. Close
$5.60
Circuit Range
N/A
Day Range
$5.55 - $6.62
Year Range
$1.92 - $9.09
Volume
2,567
Average Traded
$6.10

Cumberland Share Price Today

As of 19 November 2026, Cumberland Pharmaceuticals Inc.'s share price is $6.63. The stock opened at $5.55, compared to its previous close of $5.60. During today's trading session, Cumberland Pharmaceuticals Inc.'s share price traded between $5.55 and $6.62, with an average price of $6.08. Over the past 52 weeks, the stock has recorded a high of $9.09 and a low of $1.92. In terms of performance, Cumberland Pharmaceuticals Inc.'s share price has risen by 7.46% over the last six months and is up 185.78% on a year-on-year basis.

Cumberland Share Price Chart

Line chart of the Cumberland price trend over the selected period. The price rose overall, ranging from 5.55 to 6.63, ending at 6.63.
$5.55$6.62
L
Show Current Price
H

Cumberland Stock Fundamentals & Key Indicators

Market Cap
$98.49M
PE Ratio (TTM)
1.26
Dividend Yield
25.85%
EPS (TTM)
$4.59
Revenue (TTM)
$44.52B
Return On Equity (TTM)
94.89%
Profit Margin
-6.38%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
5616.31%

Cumberland Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$13.68$9.13$0.17$2.16
Net Profit-$1.41-$3.29-$4.28$77.78
Net Profit Margin-10.31%-36.04%-2517.65%3600.93%
Income ChangeN/A-133.33%-30.09%1917.29%

Cumberland Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$42.01$39.55$37.87$44.52
Net Profit-$5.57-$6.28-$6.48-$2.84
Net Profit Margin-13.26%-15.88%-17.11%-6.38%
Income ChangeN/A-12.75%-3.18%56.17%

Cumberland Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets39.7639.1346.0647.05
Current Assets37.0636.4535.7145.87
Total Assets76.8275.5881.7892.93
Non Current Liabilities20.4221.4224.5328.37
Current Liabilities31.8631.6227.9828.58
Total Liabilities52.2853.0452.5256.95
Shareholders' Equity24.5422.5529.2635.97

Cumberland Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating4.93-0.617.3510.54
Investing-4.710.06-0.11-13.67
Financing-6.750.2-8.68-4.15

Corporate Actions

Dividend
Ex-date: 03 Aug 2026

About Cumberland

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Cumberland Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.16
$6.62
+39.37%
Oct 2026
$7.57
$4.75
-39.41%
Sep 2026
$6.71
$7.84
-7.44%
Aug 2026
$6.01
$8.47
+25.39%
Jul 2026
$6.58
$6.75
+4.08%
Jun 2026
$6.04
$6.49
+5.19%
May 2026
$4.24
$6.17
+45.86%
Apr 2026
$3.22
$4.23
+30.96%
Mar 2026
$4.96
$3.23
-33.26%
Feb 2026
$3.81
$4.84
+28.21%
Jan 2026
$3.95
$3.77
-3.21%
Dec 2025
$2.35
$3.90
+68.10%

Cumberland Share Price FAQs